Literature DB >> 15548827

Severe proliferative retinopathy in a patient with advanced muscular dystrophy.

K Louie, R S Apte, K Mori, P Gehlbach.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15548827      PMCID： PMC1772442          DOI： 10.1136/bjo.2004.046615

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

Review 1.  Dystrophin and the retina.

Authors:  D A Pillers
Journal:  Mol Genet Metab       Date:  1999-10       Impact factor: 4.797

2.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

Review 3.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

4.  Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina.

Authors:  Cécile Dalloz; Rachel Sarig; Patrice Fort; David Yaffe; Agnès Bordais; Thomas Pannicke; Jens Grosche; Dominique Mornet; Andreas Reichenbach; José Sahel; Uri Nudel; Alvaro Rendon
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.